Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

248 ARTÍCULOS , VIENDO DEL 196 AL 210

Neuronopathic Gaucher disease: Rare in the West, common in the East

Goker-Alpan O, Ivanova MM.

J Inherit Metab Dis. 2024 Sep;47(5):917-934. doi: 10.1002/jimd.12749. Epub 2024 May 20.

An unusual case of early onset opsoclonus-myoclonus syndrome: Case report and literature review

Chávez-Nomberto RE, Díaz-Gambini MDA, Ramos Diaz KJ.

SAGE Open Med Case Rep. 2024 Sep 8;12:2050313X241281250. doi: 10.1177/2050313X241281250. eCollection 2024.

[Opsoclonus-myoclonus syndrome associated with West Nile virus]

Kazantsev AY, Nikolaeva IV, Fatkullin BS, Sozinova YM, Garipova ID.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(8):108-112. doi: 10.17116/jnevro2024124081108.

Unique Magnetic Resonance Imaging Findings in Opsoclonus-Myoclonus Syndrome Secondary to the West Nile Virus

Yang JC, Zekavaty S, Rossi RD, Mahmoud SY.

Cureus. 2024 Aug 27;16(8):e67932. doi: 10.7759/cureus.67932. eCollection 2024 Aug.

Lance-Adams Syndrome in the Intensive Care Unit: A Case Report

Angeles-Sistac D, Izura-Gomez M, Barguilla-Arribas A, Sierra-Marcos A, Moran-Chorro I.

Cureus. 2024 Apr 14;16(4):e58241. doi: 10.7759/cureus.58241. eCollection 2024 Apr.

Immune-mediated neurological syndromes associated with childhood cancers

Rossor T, Tewari S, Gadian J, Kaliakatsos M, Angelini P, Lim M.

Eur J Paediatr Neurol. 2024 Nov;53:174-181. doi: 10.1016/j.ejpn.2024.10.013. Epub 2024 Oct 31.

Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome

Prabaharan H, Chandrasekaran S, Shetty N, Nayak K P.

BMJ Case Rep. 2024 Feb 27;17(2):e256846. doi: 10.1136/bcr-2023-256846.

Establishing resources and increasing awareness to advance research on Dentatorubral-pallidoluysian atrophy toward a treatment: a patient organization perspective

Prades S, Compton A, Carroll JB.

Ther Adv Rare Dis. 2024 May 6;5:26330040241249189. doi: 10.1177/26330040241249189. eCollection 2024 Jan-Dec.

Hypertrophic olivary degeneration secondary to a Guillain Mollaret triangle cavernoma: Two case report

Marrakchi S, Hsain IH, Guelzim Y, Ech-Cherif NEK, Fikri M, Jiddane M, Touarsa F.

Radiol Case Rep. 2024 Jun 5;19(8):3538-3544. doi: 10.1016/j.radcr.2024.04.078. eCollection 2024 Aug.

Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset

Kern J, Böhringer J, Timmann D, Trollmann R, Stendel C, Kamm C, Röbl M, Santhanakumaran V, Groeschel S, Beck-Wödl S, Göricke S, Krägeloh-Mann I, Synofzik M.

Neurology. 2024 Jan 9;102(1):e207898. doi: 10.1212/WNL.0000000000207898. Epub 2023 Dec 12.

An autopsy case of MV 2K + C subtype of Creutzfeldt-Jakob disease

Uchino A, Saito Y, Tokuda S, Saburo Y, Murayama S, Hasegawa K.

Neuropathology. 2024 Aug;44(4):304-313. doi: 10.1111/neup.12964. Epub 2024 Feb 14.

[Clinical and genetic analysis of two children with TANC2 gene variants and a literature review]

Chu M, Xu D, Xie J, Zhang X, Wang M, Li J, Ma Y, Li X, Wang J, Jia T.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024 Oct 10;41(10):1195-1200. doi: 10.3760/cma.j.cn511374-20240313-00171.

Clinical features in antiglycine receptor antibody-related disease: a case report and update literature review

Wu X, Zhang H, Shi M, Fang S.

Front Immunol. 2024 Jun 17;15:1387591. doi: 10.3389/fimmu.2024.1387591. eCollection 2024.

The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1

Singh S, Hämäläinen RH.

Cells. 2024 Jan 16;13(2):170. doi: 10.3390/cells13020170.

DHDDS and NUS1: A Converging Pathway and Common Phenotype

Williams LJ, Waller S, Qiu J, Innes E, Elserafy N, Procopis P, Sampaio H, Mahant N, Tchan MC, Mohammad SS, Morales-Briceño H, Fung VSC.

Mov Disord Clin Pract. 2024 Jan;11(1):76-85. doi: 10.1002/mdc3.13920. Epub 2023 Nov 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias